Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial
Nissen, Steven E., Dent-Acosta, Ricardo E., Rosenson, Robert S., Stroes, Erik, Sattar, Naveed, Preiss, David, Mancini, G.B. John, Ballantyne, Christie M., Catapano, Alberico, Gouni-Berthold, Ioanna, SVolume:
39
Language:
english
Journal:
Clinical Cardiology
DOI:
10.1002/clc.22518
Date:
March, 2016
File:
PDF, 237 KB
english, 2016